Encapsulation of retinoids in solid lipid nanoparticles (SLN)

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Drug Delivery

Background:

• Solid lipid nanoparticles (SLN) are versatile drug carriers for various administration routes.
• Efficient drug incorporation within the SLN core is crucial but not fully understood.
• Current methods for assessing drug entrapment have limitations.

Purpose of the Study:

• To investigate drug incorporation mechanisms in SLN.
• To identify optimal lipid formulations for enhanced drug encapsulation.
• To correlate SLN structure with drug entrapment efficiency.

Main Methods:

• Developed a novel method using differential chemical stability of retinoids in lipid and aqueous phases.
• Compared drug entrapment using various lipids (glyceryl behenate, tripalmitate, cetyl palmitate, paraffin).
• Evaluated encapsulation of different polarity retinoids (tretinoin, retinol, retinyl palmitate).
• Utilized X-ray diffraction to analyze SLN crystallinity and lattice defects.

Main Results:

• Glyceryl behenate demonstrated superior entrapment compared to other lipids.
• Entrapment efficiency increased with decreasing drug polarity (retinyl palmitate > retinol > tretinoin).
• Formulating SLN from liquid-solid lipid mixtures enhanced encapsulation and drug protection.
• Low crystallinity and lattice defects in SLN correlated with good encapsulation.

Conclusions:

• Drug incorporation in SLN is influenced by lipid properties and drug polarity.
• Glyceryl behenate and less polar drugs are favorable for high encapsulation.
• SLN structure, particularly low crystallinity, is key for effective drug loading and stability.